Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

(2009) Gregory J. Dore et al.   GASTROENTEROLOGY

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

(2009) David L. Thomas et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis

(2008) David E. Kaplan et al.   JOURNAL OF HEPATOLOGY

Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV

(2008) Eishiro Mizukoshi et al.   JOURNAL OF INFECTIOUS DISEASES

HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance

(2008) T. A. Ruys et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 Production

(2008) K. Saito et al.   JOURNAL OF VIROLOGY

Functional Suppression by FoxP3+CD4+CD25highRegulatory T Cells during Acute Hepatitis C Virus Infection

(2007) Susan Smyk‐Pearson et al.   JOURNAL OF INFECTIOUS DISEASES

IL-10 and the resolution of infections

(2007) CM Filippi et al.   JOURNAL OF PATHOLOGY